1.888.321.7828 sales@pepid.com
The Obesity Epidemic

The Obesity Epidemic

Let’s take a moment in the midst of the Coronavirus Pandemic, to discuss one of the other major issues within America today: the obesity epidemic. Obesity is the term used when a person is grossly overweight. This is determined by analyzing body mass index (BMI)...

Canisius College Physician Assistant Studies Master’s Program Adopts PEPID Clinical Rotations Companion Curriculum Wide

– PEPID, the world’s leading provider of specialty medical and nursing software, and Data Soft Logic Corporation, creator of web-based point-of-care software optimized for home health, hospice, and therapy agencies, announced a ten-year renewal of their long-standing partnership. PEPID and Data Soft Logic first started working together in 2011.

Occupational Stressors of ED Physicians

Occupational Stressors of ED Physicians

The Double-edged Sword In the field of medicine, the Emergency Department presents a unique working environment that doesn’t quite compare with other clinical settings. It can be looked at as a double-edged sword. On one hand, the ED offers prestigious, high value,...
7 Reasons You Need PEPID

7 Reasons You Need PEPID

It takes a lot to provide patient-centered, evidence-based care. From dosing calculations to uncommon conditions, even the most seasoned clinician can benefit from a tool designed for the 10-second triple-check. That’s exactly what PEPID specialty-specific...
COVID-19 Compiled Resources from PEPID

COVID-19 Compiled Resources from PEPID

With the constantly evolving nature of the COVID-19 outbreak, PEPID’s goal is to be a source of evidence-based, reliable information for the healthcare community. PEPID will continue to rapidly review and update its resources concerning the COVID-19 outbreak...
Blood Test to Predict Alzheimer’s 94% Accurate

Blood Test to Predict Alzheimer’s 94% Accurate

Researchers at Washington University School of Medicine in St. Louis, MO recently reported a game changing blood test that could significantly decrease the cost of clinical trials for Alzheimer’s disease. The findings, published August 1st in the journal Neurology,...